1 Product identity
Ingredient risk
2 ingredients to use with caution
Cascara Sagrada 450 mg
BrandFDC→Botanical Capsule 4 ingredients 2 caution DSLD #25873Net contents: 90 Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-09-25
2 Ingredients (4)
IngredientGroupSafety
GelatinGelatin—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Cascara Sagrada 🇪🇺 — Hydroxyanthracene derivatives under assessment.
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Cascara Sagrada — Use with Caution
⚠ Stimulant laxative — same chronic abuse risk as senna
⚠ Electrolyte imbalance
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• All Other
5 Data source
DSLD ID25873
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-09-25
6 More from FDC
View FDC Safety Scorecard → 1 products
7 Cite this page
Vancouver
Pkhakadze G. Cascara Sagrada 450 mg — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Oct 18]. Available from: https://supplement.ge/products/cascara-sagrada-450-mg-25873/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG